Methods to study phosphorylation and activation of the hormone-sensitive adipocyte phosphodiesterase type 3B in rat adipocytes
(2001) In Methods in Molecular Biology 155. p.167-180- Abstract
- Cyclic nucleotide phosphodiesterases (PDEs) include a large group of structurally related enzymes that are responsible for the hydrolysis of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). These enzymes belong to at least nine related gene families (PDEs 1–9) (1–5), which differ in their primary structures, affinities for cAMP and cGMP, responses to specific effectors, sensitivities to specific inhibitors, and regulatory mechanisms. The PDE3 family (6) consists of two subfamilies, PDE3A and PDE3B, which exhibit tissue-specific distribution; grossly, PDE3A enzymes are expressed in the cardiovascular system, and PDE3B enzymes in insulin-sensitive cells, such as hepatocytes (7) and adipocytes (6), and also in... (More)
- Cyclic nucleotide phosphodiesterases (PDEs) include a large group of structurally related enzymes that are responsible for the hydrolysis of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). These enzymes belong to at least nine related gene families (PDEs 1–9) (1–5), which differ in their primary structures, affinities for cAMP and cGMP, responses to specific effectors, sensitivities to specific inhibitors, and regulatory mechanisms. The PDE3 family (6) consists of two subfamilies, PDE3A and PDE3B, which exhibit tissue-specific distribution; grossly, PDE3A enzymes are expressed in the cardiovascular system, and PDE3B enzymes in insulin-sensitive cells, such as hepatocytes (7) and adipocytes (6), and also in pancreatic β-cells (8). One characteristic of PDE3s involves their phosphorylation and activation in response to insulin, as well as to agents that increase cAMP in adipocytes (6), hepatocytes (7), and platelets (9–11), and in response to insulin-like growth factor-1 (IGF-)1 in pancreatic β-cells (8). (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1119824
- author
- Degerman, Eva
LU
; Resjö, Svante LU ; Landström, Tova LU and Manganiello, Vincent
- organization
- publishing date
- 2001
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Methods in Molecular Biology
- volume
- 155
- pages
- 167 - 180
- publisher
- Springer
- external identifiers
-
- pmid:11293069
- scopus:0035222384
- ISSN
- 1940-6029
- DOI
- 10.1385/1-59259-231-7:167
- language
- English
- LU publication?
- yes
- id
- 246aaea6-fea7-4731-9521-fd7a78b16b9d (old id 1119824)
- date added to LUP
- 2016-04-01 11:52:19
- date last changed
- 2025-04-04 15:33:44
@article{246aaea6-fea7-4731-9521-fd7a78b16b9d, abstract = {{Cyclic nucleotide phosphodiesterases (PDEs) include a large group of structurally related enzymes that are responsible for the hydrolysis of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). These enzymes belong to at least nine related gene families (PDEs 1–9) (1–5), which differ in their primary structures, affinities for cAMP and cGMP, responses to specific effectors, sensitivities to specific inhibitors, and regulatory mechanisms. The PDE3 family (6) consists of two subfamilies, PDE3A and PDE3B, which exhibit tissue-specific distribution; grossly, PDE3A enzymes are expressed in the cardiovascular system, and PDE3B enzymes in insulin-sensitive cells, such as hepatocytes (7) and adipocytes (6), and also in pancreatic β-cells (8). One characteristic of PDE3s involves their phosphorylation and activation in response to insulin, as well as to agents that increase cAMP in adipocytes (6), hepatocytes (7), and platelets (9–11), and in response to insulin-like growth factor-1 (IGF-)1 in pancreatic β-cells (8).}}, author = {{Degerman, Eva and Resjö, Svante and Landström, Tova and Manganiello, Vincent}}, issn = {{1940-6029}}, language = {{eng}}, pages = {{167--180}}, publisher = {{Springer}}, series = {{Methods in Molecular Biology}}, title = {{Methods to study phosphorylation and activation of the hormone-sensitive adipocyte phosphodiesterase type 3B in rat adipocytes}}, url = {{http://dx.doi.org/10.1385/1-59259-231-7:167}}, doi = {{10.1385/1-59259-231-7:167}}, volume = {{155}}, year = {{2001}}, }